您的位置: 首页 > 农业专利 > 详情页

The combination of IL-2R beta selective agonists and long-acting IL-15 agonists
专利权人:
ネクター セラピューティクス
发明人:
チャリッチ, デボラ エイチ.,カーク, ピーター
申请号:
JP2018517898
公开号:
JP2018530568A
申请日:
2016.10.07
申请国别(地区):
JP
年份:
2018
代理人:
摘要:
In one or more embodiments of the present invention, it provides a method, this method includes the steps that giving to cancer patient following: (a) the long-acting IL-2R beta selective agonists of IL-2R β volume of activation And (b) long-acting parts IL-15 of IL-15R volume of activation. In one or more embodiments of the present invention, a kind of composition is provided, the composition includes: the long-acting IL-2R beta selective agonists of IL-2R β volume of activation And the long-acting parts IL-15 of IL-15R volume of activation. In one or more embodiments of the present invention, a kind of kit is provided, which includes: the long-acting IL-2R beta selective agonists of IL-2R β volume of activation The long-acting parts IL-15 of IL-15R volume of activation And the operation instructions of the IL-2R beta selective agonists and the long-acting parts IL-15.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充